Why does it seem to be so hard to understand what the headline of the press release states, and the text of the press release explains further?

Headline excerpt:

to Develop and Commercialize Brilacidin for Ulcerative Proctitis/Proctosigmoiditis

Quote:

---

for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.

The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.

---

Link to complete release:

http://www.ipharminc.com/press-release/2019/5...igmoiditis